Ketamine: reclassification alone will not reduce harms
Adam Winstock, David Nutt, Caroline S Copeland
BMJ February 3, 2026 DOI: 10.1136/bmj.s222 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary or opinion piece Peer reviewed |
|---|---|
| Topics | Esketamine Ketamine |
| Keywords | Public health Internet privacy Medline Gesture Data science Computer security |
| Key points | Argues that reclassifying ketamine without parallel public health action risks being a symbolic gesture rather than a strategy to reduce harm. |
Abstract
Without parallel public health action, reclassifying ketamine risks being a symbolic gesture rather than a strategy to reduce harm, write Adam Winstock, David Nutt, and Caroline Copeland